# SUMATRIPTAN SUCCINATE
> **ANDA215651** · Abbreviated New Drug Application (Generic) · Sponsor: ONESOURCE SPECIALTY · Approved 2024-11-21
## Drug
- **FDA Application Number:** ANDA215651
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SUMATRIPTAN SUCCINATE
- **Generic name:** SUMATRIPTAN
- **Active ingredients:** SUMATRIPTAN SUCCINATE
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** ONESOURCE SPECIALTY
- **Manufacturer:** ONESOURCE SPECIALTY PHARMA LIMITED
- **First approval:** 2024-11-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215651)
---
*AI Analytics · CC0 1.0*